Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy-Reference-Cited by-同舟云学术

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy

Published:2021-02-09 Issue:4 Volume:110 Page:888-896
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Crews Kristine R.¹,Monte Andrew A.²,Huddart Rachel³,Caudle Kelly E.¹,Kharasch Evan D.⁴,Gaedigk Andrea⁵⁶,Dunnenberger Henry M.⁷,Leeder J. Steven⁵⁶,Callaghan John T.⁸,Samer Caroline Flora⁹,Klein Teri E.³,Haidar Cyrine E.¹,Van Driest Sara L.¹⁰,Ruano Gualberto¹¹,Sangkuhl Katrin³,Cavallari Larisa H.¹²,Müller Daniel J.¹³,Prows Cynthia A.¹⁴,Nagy Mohamed¹⁵,Somogyi Andrew A.¹⁶,Skaar Todd C.⁸

Affiliation:

1. Department of Pharmaceutical Sciences St. Jude Children’s Research Hospital Memphis Tennessee USA

2. Department of Emergency Medicine & Colorado Center for Personalized Medicine University of Colorado School of Medicine Aurora Colorado USA

3. Department of Biomedical Data Science Stanford University Stanford California USA

4. Department of Anesthesiology Duke University School of Medicine Durham North Carolina USA

5. Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation Children’s Mercy Kansas City Kanas City Missouri USA

6. School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA

7. Neaman Center for Personalized Medicine NorthShore University HealthSystem Evanston Illinois USA

8. Department of Medicine Division of Clinical Pharmacology Indiana University School of Medicine Indianapolis Indiana USA

9. Clinical Pharmacology and Toxicology Department Geneva University Hospitals Geneva Switzerland

10. Departments of Pediatrics and Medicine Vanderbilt University Medical Center Nashville Tennessee USA

11. Institute of Living Hartford Hospital Genomas Lab of Personalized Health University of Connecticut School of Medicine and University of Puerto Rico Medical Sciences Hartford Connecticut USA

12. Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine University of Florida Gainesville Florida USA

13. Department of Psychiatry Campbell Family Mental Health Research Institute of CAMHUniversity of Toronto Toronto Ontario Canada

14. Divisions of Human Genetics and Patient Services Cincinnati Children’s Hospital Medical Center Cincinnati Ohio USA

15. Department of Pharmaceutical Services Children’s Cancer Hospital Egypt 57357 Cairo Egypt

16. Discipline of Pharmacology Adelaide Medical School University of Adelaide Adelaide Australia

Funder

National Institutes of Health

National Health and Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2149

Reference55 articles.

1. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

2. PharmGKB.Gene Reference Materials for CYP2D6. Accessed December 1 2020.

3. CPIC.CPIC Guideline for Opioids based on genotype.

4. The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

5. Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results;Genetics in Medicine;2024-04

2. Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation;European Journal of Pharmaceutical Sciences;2024-03

3. Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes;Annual Review of Pharmacology and Toxicology;2024-01-23

4. The Case for Pre-Emptive Pharmacogenetic Screening in South Africa;Journal of Personalized Medicine;2024-01-19

5. Molecular mechanisms underlying single nucleotide polymorphism-induced reactivity decrease in CYP2D6;2024-01-04